Literature DB >> 8185642

Characterization of cloned human cholecystokinin-B receptor as a gastrin receptor.

A Miyake1, S Mochizuki, H Kawashima.   

Abstract

The cholecystokinin (CCK)-B receptor cloned from human brain was characterized as a gastrin receptor by using heterologous expression systems of COS-7 cells and Xenopus oocytes. 125I-gastrin binding to human CCK-B receptor expressed in COS-7 was time-dependent, saturable and also specific, as well as 125-I-CCK-8. The binding of 125I-gastrin was inhibited by CCK-8 about 10-fold more potently than by gastrin. The rank order of potency of several antagonists to 125I-gastrin binding was YM022 > CI-988 > L-365,260 > L-364,718. Addition of GTP gamma S, a nonhydrolysable analog of GTP, dose-dependently inhibited 125I-gastrin binding, and lowered the gastrin binding affinity, Gastrin (10(-9)-10(-7) M) also evoked a Ca(2+)-dependent Cl- current in Xenopus oocytes expressing CCK-B receptors. These results suggest that the pharmacological profile of the cloned human CCK-B receptor using 125I-gastrin is closely parallel to that reported in gastric mucosa, and that the receptor transduces cellular signals of gastrin as well as those of CCK-8.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8185642     DOI: 10.1016/0006-2952(94)90332-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells.

Authors:  E Lindström; M Björkqvist; R Håkanson
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.

Authors:  H Yuki; A Nishida; A Miyake; H Ito; S Akuzawa; Y Takinami; Y Takemoto; K Miyata
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

3.  Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022.

Authors:  T Murayama; Y Matsumori; N Iwata; M Ito; T Taniguchi; K Chihara; T Matsui
Journal:  Jpn J Cancer Res       Date:  1996-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.